Soliton Inc (SOLY) Stock Price, Forecast & Analysis
NASDAQ:SOLY
SOLY Key Statistics, Chart & Performance
The current stock price of SOLY is 22.58 null. In the past month the price increased by 8.66%. In the past year, price increased by 170.42%.
SOLY Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SOLY. When comparing the yearly performance of all stocks, SOLY is one of the better performing stocks in the market, outperforming 97.92% of all stocks.
SOLY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SOLY. SOLY has a great financial health rating, but its profitability evaluates not so good.
SOLY Financial Highlights
Over the last trailing twelve months SOLY reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS decreased by -18.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -4832.43% | ||
| ROA | -69.93% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
SOLY Forecast & Estimates
8 analysts have analysed SOLY and the average price target is 23.05 null. This implies a price increase of 2.09% is expected in the next year compared to the current price of 22.58.
SOLY Ownership
SOLY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.62 | 193.832B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.53 | 169.664B | ||
| SYK | STRYKER CORP | 24.21 | 139.908B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.34 | 109.921B | ||
| BDX | BECTON DICKINSON AND CO | 11.16 | 50.66B | ||
| IDXX | IDEXX LABORATORIES INC | 42.48 | 49.283B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.52 | 44.358B | ||
| RMD | RESMED INC | 20.57 | 35.869B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16 | 35.845B | ||
| DXCM | DEXCOM INC | 27.73 | 25.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SOLY
Company Profile
Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-02-19. The firm is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). The company develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It’s designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.
Company Info
Soliton Inc
5304 Ashbrook Dr
Houston TEXAS 77081 US
CEO: Brad Hauser
Employees: 13
Phone: 18326613453.0
Soliton Inc / SOLY FAQ
What does Soliton Inc do?
Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-02-19. The firm is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). The company develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It’s designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.
Can you provide the latest stock price for Soliton Inc?
The current stock price of SOLY is 22.58 null. The price increased by 0.13% in the last trading session.
What is the dividend status of Soliton Inc?
SOLY does not pay a dividend.
What is the ChartMill technical and fundamental rating of SOLY stock?
SOLY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of SOLY stock?
Soliton Inc (SOLY) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How is the valuation of Soliton Inc (SOLY) based on its PE ratio?
Soliton Inc (SOLY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.85).
What is Soliton Inc worth?
Soliton Inc (SOLY) has a market capitalization of 485.90M null. This makes SOLY a Small Cap stock.